Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-3-30
pubmed:abstractText
Serum osteocalcin and C-terminal telopeptides of type-1 collagen (CTX-1) are known markers of bone turnover, whereas the role of fibroblast growth factor 23 (FGF-23) is yet unknown. We investigated early changes in bone mass and the association of these biochemical markers and FGF-23 with bone loss following renal transplantation (RTx).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1502-7686
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
161-7
pubmed:meshHeading
pubmed-meshheading:18972258-Absorptiometry, Photon, pubmed-meshheading:18972258-Adult, pubmed-meshheading:18972258-Aged, pubmed-meshheading:18972258-Biological Markers, pubmed-meshheading:18972258-Bone Density, pubmed-meshheading:18972258-Bone and Bones, pubmed-meshheading:18972258-Collagen Type I, pubmed-meshheading:18972258-Female, pubmed-meshheading:18972258-Fibroblast Growth Factors, pubmed-meshheading:18972258-Humans, pubmed-meshheading:18972258-Immunosuppressive Agents, pubmed-meshheading:18972258-Kidney Transplantation, pubmed-meshheading:18972258-Male, pubmed-meshheading:18972258-Middle Aged, pubmed-meshheading:18972258-Organ Size, pubmed-meshheading:18972258-Osteocalcin, pubmed-meshheading:18972258-Parathyroid Hormone, pubmed-meshheading:18972258-Peptides, pubmed-meshheading:18972258-Prospective Studies, pubmed-meshheading:18972258-Vitamin D
pubmed:year
2009
pubmed:articleTitle
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation.
pubmed:affiliation
Medical Center, Rikshospitalet-Radiumhospitalet, University of Oslo, Oslo, Norway. szilveszter.dolgos@rikshospitalet.no
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't